ArticlePharmaceutical medicine2023

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond.

Lisa Gieber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.